Literature DB >> 8567327

External radiotherapy for carcinoma of the eyelid: report of 850 cases treated.

P Schlienger1, F Brunin, L Desjardins, M Laurent, C Haye, J R Vilcoq.   

Abstract

PURPOSE: We report a retrospective series of 850 patients treated by external irradiation for carcinoma of the eyelid at Institut Curie and we compare our results with other techniques: brachytherapy and surgery. METHODS AND MATERIALS: Eight hundred fifty patients were treated by external radiotherapy for carcinoma of the eyelid. None of these patients have been previously treated. All the patients were classified according to the TNM classification of (UICC). We distinguished five histological types and five clinical groups according to the site of the skin tumor. Three modalities of external radiotherapy were used: contact therapy, conventional radiotherapy, and electrontherapy. We reviewed the clinical files of the 850 patients who went regularly at follow-up visits.
RESULTS: We report the 5-year survival results--alive with no evidence of disease: 72%; alive with progression: 2%; died from tumor progression: 0.5%; died from intercurrent disease: 19.5%; and lost to follow-up: 5%. The 5-year local control rate was 97.5%. We observed 45 failures--lymph node, metastatic, and local--and emphasize this last group by presenting the results of treatment of these local failures. We studied the complications of treatment: 2.3% of corneal complications, 2% of cataracts, and 1.4% of serious ocular complications.
CONCLUSIONS: Our results concerning local failures and loss of the eye are comparable to those reported for other techniques involving brachytherapy or surgery. Overall, external radiotherapy is a safe and effective treatment, as it ensures a high local control rate and provides perfectly satisfactory functional and esthetic results. It seemed particularly useful to report this series in that few publications are available on this subject that, nevertheless, constitutes a topical issue.

Entities:  

Mesh:

Year:  1996        PMID: 8567327     DOI: 10.1016/0360-3016(95)02135-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Electron therapy for orbital and periorbital lesions using customized lead eye shields.

Authors:  Keiji Hayashi; Kunito Hatsuno; Ryo-ichi Yoshimura; Toshiaki Iida; Fumio Ayukawa; Kazuma Toda; Hisashi Taniguchi; Hitoshi Shibuya
Journal:  Ophthalmologica       Date:  2008-11-26       Impact factor: 3.250

2.  Interstitial brachytherapy for eyelid carcinoma. Outcome analysis in 60 patients.

Authors:  M Krengli; L Masini; A M Comoli; E Negri; L Deantonio; A Filomeno; G Gambaro
Journal:  Strahlenther Onkol       Date:  2014-01-16       Impact factor: 3.621

Review 3.  Oculoplastic aspects of ocular oncology.

Authors:  C Rene
Journal:  Eye (Lond)       Date:  2012-11-30       Impact factor: 3.775

4.  Reirradiation for Recurrent Scalp Angiosarcoma: Dosimetric Advantage of PBT over VMAT and EBT.

Authors:  Tal Eitan; Nicholas J Damico; Rajesh Pidikiti; Michael Z Kharouta; Donald Dobbins; Frederick B Jesseph; Mark Smith; Ankit Mangla; Theodoros N Teknos; David B Mansur; Mitchell Machtay; Min Yao; Aashish D Bhatt
Journal:  Int J Part Ther       Date:  2019-12-16

5.  Proton Beam Therapy in the Treatment of Periorbital Malignancies.

Authors:  Nicholas J Damico; Anna K Wu; Michael Z Kharouta; Tal Eitan; Rajesh Pidikiti; Frederick B Jesseph; Mark Smith; Christian Langmack; Diana L Mattson; Donald Dobbins; David B Mansur; Mitchell X Machtay; Jennifer A Dorth; Serah Choi; Min Yao; Aashish D Bhatt
Journal:  Int J Part Ther       Date:  2021-03-26

6.  Results of radical radiotherapy for squamous cell carcinoma of the eyelid.

Authors:  Koji Inaba; Yoshinori Ito; Shigenobu Suzuki; Shuhei Sekii; Kana Takahashi; Yuuki Kuroda; Naoya Murakami; Madoka Morota; Hiroshi Mayahara; Minako Sumi; Takashi Uno; Jun Itami
Journal:  J Radiat Res       Date:  2013-06-07       Impact factor: 2.724

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.